Daniel Estes
InvestorGeneral Partner at Frazier Life Sciences · General Partner at Frazier Healthcare Partners · Board director at Eyconis · Board director at Radionetics Oncology
San Diego
Find your path to Daniel
1,520 people in our graph share verified history with Daniel — schools, employers, funds. One of them is your warm intro.
About
Dan Estes is a General Partner at Frazier Life Sciences, which he joined in 2011, where he invests in development-stage and commercial-stage pharmaceutical companies. He has co-founded and helped launch several portfolio companies and previously worked as a management consultant in McKinsey & Company's healthcare practice, advising pharmaceutical and biotech firms on R&D and business development strategy. He holds a Ph.D. in Biomedical Engineering from the University of Michigan and a B.S. in Electrical Engineering from Stanford University.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Eyconis
Intro paths
In turn, Daniel can intro founders to Eyconis's investors below.
Board director at Eyconis
Intro paths
In turn, Daniel can intro founders to Eyconis's investors below.
Board director at Radionetics Oncology
Intro paths
In turn, Daniel can intro founders to Radionetics Oncology's investors below.
Radionetics Oncology's investors · 6
Experience
- Frazier Life SciencesGeneral Partnercurrent2011 — presentSan Diego, CA
- McKinsey & CompanyBiotechnology Consultant2008 — 2011Palo Alto, CA
Deals · 2
Hummingbird BioscienceLed round
Sierra OncologyLed round
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
AlestaHIllstar BioTarsus Pharmaceuticals
Board seats
Investor
Acerta Pharma BVAlestaArcutisBluejay TherapeuticsCallio BioCallio TherapeuticsEyconisHillStar BioIgnytaInipharmIolyxIolyxIovanceLengo TherapeuticsPreCision DermatologyRadionetics OncologySidewinder TherapeuticsSudo BioSudo BioTobira TherapeuticsTranslate BioVaxcyte
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at Frazier Life Sciences
Network5
Investors connected to Daniel in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Daniel Estes?
- Dan Estes is a General Partner at Frazier Life Sciences, which he joined in 2011, where he invests in development-stage and commercial-stage pharmaceutical companies. He has co-founded and helped launch several portfolio companies and previously worked as a management consultant in McKinsey & Company's healthcare practice, advising pharmaceutical and biotech firms on R&D and business development strategy. He holds a Ph.D. in Biomedical Engineering from the University of Michigan and a B.S. in Electrical Engineering from Stanford University.
- Where does Daniel Estes work?
- Daniel Estes is General Partner at Frazier Life Sciences and Board director at Eyconis and Board director at Eyconis and Board director at Radionetics Oncology.
- What does Daniel Estes invest in?
- Daniel Estes invests in Biotech.
- What boards does Daniel Estes sit on?
- Daniel Estes holds tracked board seats at Arcutis.
- What companies has Daniel Estes invested in?
- Investments tracked here include Alesta, HIllstar Bio, Hummingbird Bioscience, Sierra Oncology, Tarsus Pharmaceuticals, Acerta Pharma BV, Alesta, Arcutis, Bluejay Therapeutics, Callio Bio, Callio Therapeutics, Eyconis, and 16 more.
- Where did Daniel Estes go to school?
- Daniel Estes studied at University of Michigan (PhD, Biomedical Engineering); Stanford University (BS, Electrical Engineering).
- Does Daniel Estes lead rounds?
- Yes — Daniel Estes has led 5 tracked investments.
Same school
Also attended University of Michigan1,028
+ 1,022 more
Also attended Stanford University2,000
+ 1,994 more
Shared employers
Also worked at McKinsey & Company2,000
+ 1,994 more